drugset / Trial / NCT05031481
Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of different doses of Venus association in the treatment of vulvovaginal candidiasis.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2023-12
- Completion
- 2024-03
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Butoconazole | Small molecule | 100 mg | Other |
| Subject | Venus | Unknown | 0.064 unknown | Other |
| Subject | Venus | Unknown | 1 unknown | Other |
| Subject | Venus | Unknown | 4 unknown | Other |
| Subject | Venus | Unknown | 20 unknown | Other |